ArticleNAR cancer2026
Efficient gene disruption with CRISPR-Cas3 in human T cells.
Tomoaki Fujii et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleNAR cancer2026
Tomoaki Fujii et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.